NOVEMBER 4-7, 2019 - VIVA Physicians
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
THE GLOBAL
EDUCATION COURSES
FOR VASCULAR
MEDICINE AND
INTERVENTION
Venous Endovascular
INterventional Strategies
NOVEMBER 2-4, 2019
Vascular InterVentional Advances
N O V E M B E R 4 - 7, 2 0 1 9
WYNN LAS VEGAS
VIVA Physicians is a not-for-profit organization
dedicated to vascular education and research
vivaphysicians.org
VIVA is a not-for-profit organization that began in 2003 as a way to fill an educational gap in peripheral
vascular disease management: a truly multidisciplinary conference providing a platform to exchange
the latest in image-guided interventions. The founding Course Directors recognized the potential to
improve the vascular field by bringing together peers from interventional cardiology, vascular medicine,
interventional radiology, and vascular surgery. The board members brought together their individual
regional specialty meetings to form the original VIVA conference, enhancing the opportunity to showcase
data, techniques, and device developments to a wider audience. From the start, VIVA attendees could
experience the benefits to patient care that were made possible by interdisciplinary collaboration.
Now, 17 years later, VIVA continues to find innovative ways to share information among all vascular
specialties. VIVA has raised the standards for vascular interventions and, along with The VEINS, has
sought to provide the best education possible from a diverse faculty of experts.
Throughout the years, VIVA’s educational strategy has evolved to include a variety of learning modalities
and venues. This year, VIVA and The VEINS will highlight:
n Imaging and interventional hands-on labs
n Groundbreaking research and trial data in our Late-Breaking Clinical Trial sessions
n S
mall-theater experiences: the case-based Strategies on the Frontline and the expert discussion-
centered Roundtable
n The Purple Theater’s focus on the business of healthcare and innovative technologies
n Pre-courses focused on CLI care and aortic intervention
n Half-day pharmacotherapy and AV dialysis pre-courses
VIVA Physcians’ core values are education through our annual conferences; advocacy of critical
regulatory, reimbursement, and disease state developments; and research. For more information about
our involvement in the PVD care community, please visit www.vivaphysicians.org.
Founders
GARY ANSEL, MD JAMES JOYE, DO
Interventional Cardiology Interventional Cardiology
OhioHealth Riverside Methodist Hospital/ El Camino Hospital
McConnell Heart Hospital Mountain View, California
Columbus, Ohio
JOHN LAIRD JR, MD
MICHAEL DAKE, MD Interventional Cardiology
Interventional Radiology Adventist St. Helena Hospital
The University of Arizona St. Helena, California
Tucson, Arizona
KRISHNA ROCHA-SINGH, MD
TONY DAS, MD Interventional Cardiology
Interventional Cardiology Prairie Heart Institute at St. John’s Hospital
Cardiology & Interventional Vascular Associates Springfield, Illinois
Dallas, Texas
KENNETH ROSENFIELD, MD
MICHAEL JAFF, DO Interventional Cardiology
Vascular Medicine Massachusetts General Hospital
Newton-Wellesley Hospital, Boston, Massachusetts
Harvard Medical School
Newton, Massachusetts TIM SULLIVAN, MD
Vascular Surgery
Allina Health
Minneapolis, Minnesota
2 Please visit vivaphysicians.org for
updated program information.
Table of Contents
2019 Highlights . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4 The VEINS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33
CME Accreditation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5 Course Directors/Scientific Committee . . . . . . . . . . . . 34
CE Accreditation: Nurses + Techs . . . . . . . . . . . . . . . . . . 6 Invited Faculty . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 34-35
Board of Directors/Scientific Committee . . . . . . . . . . . . . 7 CME Accreditation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 36
Invited Faculty . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8-10 Agenda . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 37-41
VIVA Award Recipients . . . . . . . . . . . . . . . . . . . . . . . . . . . 11
Schedule At-A-Glance . . . . . . . . . . . . . . . . . . . . . . . . . 12-13 Saturday
Agenda . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14-27 The Basics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 37
Breakout Hands-On Sessions . . . . . . . . . . . . . . . . . . . . 37
Monday Pre-Courses
Aortic Armageddon . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14 Sunday
Critical Limb Ischemia . . . . . . . . . . . . . . . . . . . . . . . . . . 15 The VEINS General Session . . . . . . . . . . . . . . . . . . 38-39
Dialysis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16 The VEINS Award Recipient . . . . . . . . . . . . . . . . . . . . 38
PharmacoRx . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16
Monday
Tuesday Blue Sky Breakfast . . . . . . . . . . . . . . . . . . . . . . . . . . . . 40
Global Theater . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17-18 The VEINS General Session . . . . . . . . . . . . . . . . . . 40-41
The Roundtable . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 19
Strategies on the Frontline . . . . . . . . . . . . . . . . . . . . . . 19
Purple Theater . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 19
Registration . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 42
Wednesday
EARLY
Aortic and CLI Morning Tracks . . . . . . . . . . . . . . . . . . 20
Global Theater . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20-21 ENDS JULY 11
Roundtable . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21-22
PRIME
Strategies on the Frontline . . . . . . . . . . . . . . . . . . . . . 22
Purple Theater . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23 JULY 12–SEPTEMBER 16
STANDARD
Thursday
Aortic and CLI Morning Tracks . . . . . . . . . . . . . . . . . . 24 SEPTEMBER 17–NOVEMBER 7
Global Theater . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24-25
Roundtable . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 26
Strategies on the Frontline . . . . . . . . . . . . . . . . . . . . . 27
Accommodations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 43
Purple Theater . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27
LAST DAY TO BOOK HOTEL
Nurses + Techs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 28
Face-Off . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 29
SEPTEMBER 29
(based on availability)
Supporters and Exhibitors . . . . . . . . . . . . . . . . . . . . . 30-31
Disclaimers . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 31
Virtual VIVA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 32
3
2019 HIGHLIGHTS
Live Case Sites VIVA Vascular Innovation Lab
Leading experts from around the world will be sharing the latest
A Hands-On Experience
techniques and methods for some of the most challenging
cases. Live cases showcase procedures from three continents The 2nd annual Vascular Innovation Lab offers VIVA attendees
with discussion from multispecialty panels in the Global a unique opportunity to explore peripheral vascular imaging,
Theater to evaluate and investigate different approaches to access, and intervention techniques on cadaveric specimens.
endovascular therapy. These artificially revascularized lower limbs provide a pulsatile,
lifelike “blood flow,” and are the perfect model for practicing:
J. Michael Bacharach, MD
n Vessel prep and ballooning
North Central Heart
Sioux Falls, South Dakota n Pedal and other lower extremity access
n SFA and popliteal vessel access
Tony Das, MD
The Heart Hospital Baylor Plano n Stent placement
Dallas, Texas n P
TA modalities from laser to directional coronary
atherectomy (DCA) to orbital and rotational
Andrew Holden, MBChB
Auckland Hospital This year we’ll offer two industry-sponsored sessions on
Auckland, New Zealand Wednesday with multiple tables showcasing a variety of
applications, techniques, and products. Pre-registration is not
Jason T. Lee, MD
required, but these popular labs will fill up quickly. Early arrival
Stanford University Medical Center
is advised.
Stanford, California
Andrej Schmidt, MD
University Hospital Leipzig
Leipzig, Germany
Official Publication
AV Dialysis Pre-Course
This pre-course will feature a dedicated session on the latest
technology, trials, and treatments related to AV dialysis,
including: Endorsements
n Tunneled catheters
n Stent grafts in dialysis access
n Strategies for percutaneous declotting
n Percutaneous arteriovenous fistula
n DCBs in dialysis access
4 Please visit vivaphysicians.org for
updated program information.
CME Accreditation
This program has been planned and implemented in accordance Target Audience
with the Essential Areas and Policies of the Accreditation
VIVA is designed for physicians specializing in interventional
Council for CME (ACCME) through joint providership with
cardiology; interventional and neurologic radiology; vascular
the University at Buffalo Jacobs School of Medicine and
medicine; vascular, neurologic, and cardiothoracic surgery;
Biomedical Sciences and VIVA Physicians. The University at
podiatry; fellows and residents; and allied health professionals
Buffalo Jacobs School of Medicine and Biomedical Sciences is
(including nurses, vascular clinic staff, endovascular operating
accredited by the ACCME to provide CME for physicians.
room staff, cath lab and angiography suite staff, nurse
The University at Buffalo Jacobs School of Medicine and practitioners, vascular technologists, and physician assistants).
Biomedical Sciences designates this live activity for a
maximum of 27.75 AMA PRA Category 1 CreditsTM.
Monday
Physicians should claim only the credit commensurate with
the extent of their participation in the activity. n Aortic Armageddon: 3.75
n Critical Limb Ischemia: 7.25
Objectives n Dialysis: 3.25
At the conclusion of the course, participants should be able to: n Pharmacotherapy: 3.25
n Understand the current indications, risks, complications,
Tuesday
and outcomes of medical, interventional, and surgical
therapies for the treatment of peripheral arterial, venous n Global Theater: 6.75
diseases and hemodialysis vascular access.
n The Roundtable: 2.25
n Incorporate advanced medical, endovascular, and surgical
techniques and approaches into their own practices to
improve patient care and outcomes. Wednesday
n Implement high-quality, guidelines-based programs to
n Aortic Track: 0.75
improve the early identification and care of patients with
noncardiac vascular conditions. n CLI Track: 0.75
n Increase knowledge in critical decision-making and the n Global Theater: 6.5
comprehensive spectrum of care for patients with stroke
n The Roundtable: 4.5
and intracranial and extracranial carotid artery disease.
n Improve the delivery of balanced and scientifically valid
vascular care in accordance with expert opinion and Thursday
practice.
n Aortic Track: 0.75
n Utilize strategies learned from the meeting, including
n CLI Track: 0.75
endovascular technologies, open surgical techniques, and
hybrid approaches, for the treatment of patients with n Global Theater: 5.75
aortic diseases and hemodialysis vascular access.
n The Roundtable: 5.25
n To gain and employ decision-making and procedural
strategies and techniques in patients with hemodialysis
vascular access, aortic and visceral aneurysms, dissections,
deep venous thrombosis, venous insufficiency, and
pulmonary embolism.
n Enhance the understanding and treatment skills across the
entire range of venous physiology, anatomy, diseases, and
management options and hemodialysis vascular access.
n Gain and then disseminate the most current knowledge
regarding vascular care as learned from experts in the
field, exposure to live cases, and data from late-breaking
clinical trials.
5
CE Accreditation: Nurses + Techs
Target Audience CE Accreditation Information
The target audience for the Nurses + Techs program is nurses,
physician assistants, nurse practitioners, and technologists NURSES: This continuing nursing education activity,
who work in cardiovascular care, cath labs, angiography suites, file 22704, was approved by the American Association
and endovascular operating rooms. of Critical-Care Nurses, an accredited approver by the
American Nurses Credentialing Center’s Commission on
Accreditation.
Objectives
ANCC Accredited Approver number A0012.
At the conclusion of the course, the targeted learners should
be able to: This activity was approved for 13.91 contact hours. To
receive CE credit, you must attend the program in its
n L
ist current and future options to decrease patient entirety and complete both the course evaluations and
complications related to different imaging modalities, the posttest.
especially in lower extremities.
n C
ompare devices, techniques, and complications of
endovascular interventions in CLI, carotid artery disease, TECHNOLOGISTS: This program has been approved by
aortic aneurysms, and acute venous disorders to the American Society of Radiologic Technologists (ASRT)
optimize outcomes. for 15.75 Category A continuing education credits. In order
n R
eview pharmacotherapeutic and systemic to receive credit, you will be required to scan in and out of
anticoagulation considerations in the patient with PAD, each session room. You will also be required to attend the
including postsurgical/postintervention issues and entirety of the daily sessions outlined below. Partial credit
follow-up. will not be awarded.
n O
utline best practices for patients with PAD and aortic Monday
aneurysms, from screening to procedure to follow-up.
n D
iscuss an interdisciplinary approach to the treatment n 7:45AM – 12:00PM and 1:15PM – 5:00PM
and workup of DVT. 8.5 Category A credits
n D
escribe how to perform an accurate vascular
Tuesday
assessment pre- and postintervention.
n D
iscuss maintaining an outpatient endovascular n 8:05AM – 12:00PM and 1:15PM – 5:15PM
suite efficiently in regard to staffing, safety, cost, and 7.25 Category A credits
databases.
Registered Physician in Vascular Interpretation
(RPVI) Information
A portion of your CME credits from VIVA will fulfill your
continuing education requirement if you are credentialed by
the American Registry of Diagnostic Medical Sonographers
(ARDMS) or the Alliance for Physician Certification &
Advancement (APCA). Please print your CME certificate
and submit it to the APCA with your renewal materials.
Presentations from the conference have been identified
as appropriate for ARDMS/APCA credits by the course
directors; physicians should only claim credits commensurate
with their participation. Presentations that are appropriate
for RPVI submission will be indicated as such in the course
materials at the program. For more information about RPVI
certification, visit apca.org.
6 Please visit vivaphysicians.org for
updated program information.
Board of Directors
Gary Ansel, MD John Laird Jr, MD John Rundback, MD
Interventional Cardiology Interventional Cardiology Interventional Radiology
OhioHealth Riverside Methodist Adventist St. Helena Hospital Interventional Institute, Holy Name
Hospital/McConnell Heart Hospital St. Helena, California Medical Center
Columbus, Ohio Teaneck, New Jersey
Sean Lyden, MD
Joshua Beckman, MD Vascular Surgery Saher Sabri, MD
Vascular Medicine Cleveland Clinic Interventional Radiology
Vanderbilt University Medical Center Cleveland, Ohio MedStar Washington Hospital Center
Nashville, Tennessee Washington, DC
D. Christopher Metzger, MD
Tony Das, MD Interventional Cardiology Peter A. Schneider, MD
Interventional Cardiology Wellmont CVA Heart Institute Vascular Surgery
Cardiology & Interventional Vascular Kingsport, Tennessee University of California
Associates San Francisco
Dallas, Texas Krishna Rocha-Singh, MD San Francisco, California
Interventional Cardiology
John A. Kaufman, MD Prairie Heart Institute at Niten Singh, MD
Interventional Radiology St. John’s Hospital Vascular Surgery
Dotter Interventional Institute Springfield, Illinois Harborview Medical Center
Portland, Oregon Seattle, Washington
Kenneth Rosenfield, MD
Raghu Kolluri, MD Interventional Cardiology
Vascular Medicine Massachusetts General Hospital
OhioHealth Riverside Methodist Boston, Massachusetts
Hospital
Columbus, Ohio
Scientific Committee
Ehrin Armstrong, MD Robert Lookstein, MD Ravish Sachar, MD
Interventional Cardiology Interventional Radiology Interventional Cardiology
Denver VA Medical Center Mount Sinai Medical Center UNC-REX
Denver, Colorado New York, New York Raleigh, North Carolina
Marc Bonaca, MD Sanjay Misra, MD Peter A. Schneider, MD
Vascular Medicine Interventional Radiology Vascular Surgery
Brigham and Women’s Hospital Mayo Clinic University of California
Boston, Massachusetts Rochester, Minnesota San Francisco
San Francisco, California
Jason T. Lee, MD Parag J. Patel, MD, MS
Vascular Surgery Interventional Radiology Niten Singh, MD
Stanford University Medical College of Wisconsin Vascular Surgery
Stanford, California Milwaukee, Wisconsin Harborview Medical Center
Seattle, Washington
7
Invited Faculty
George Adams, MD Teresa Carman, MD Bart Dolmatch, MD
Interventional Cardiology Vascular Medicine Interventional Radiology
UNC REX Healthcare University Hospitals Case PAMF
Raleigh, North Carolina Medical Center Mountain View, California
Cleveland, Ohio
Frank Arko, MD Matthew Eagleton, MD
Vascular Surgery Jeff Carr, MD Vascular Surgery
Sanger Heart and Vascular Institute Interventional Cardiology Cleveland Clinic
Concord, North Carolina Tyler Cardiac and Endovascular Center Cleveland, Ohio
Tyler, Texas
Bulent Arslan, MD Mark Eskandari, MD
Interventional Radiology Neal S. Cayne, MD Vascular Surgery
Rush University Medical Center Vascular Surgery Northwestern Medicine Feinberg School
Chicago, Illinois NYU Langone Medical Center of Medicine
New York, New York Chicago, Illinois
Ali Azizzadeh, MD
Vascular Surgery Rabih Chaer, MD Andres Fajardo, MD
Cedars-Sinai Smidt Heart Institute Vascular Surgery Vascular Surgery
Los Angeles, California University of Pittsburgh Medical Center Indiana University School of Medicine
Pittsburgh, Pennsylvania Indianapolis, Indiana
Amanda Bailey, CNP
Interventional Cardiology Venita Chandra, MD Mark Farber, MD
OhioHealth Heart and Vascular Vascular Surgery Vascular Surgery
Physicians Stanford University Medical Center University of North Carolina
Columbus, Ohio Stanford, California Chapel Hill, North Carolina
Subhash Banerjee, MD Daniel Clair, MD Aloke Finn, MD
Interventional Cardiology Vascular Surgery Interventional Cardiology
UT Southwestern & VA North Texas Palmetto Health/University of South University of Maryland School
Dallas, Texas Carolina Medical Group of Medicine
Columbia, South Carolina Baltimore, Maryland
Mark Bates, MD, DSc
Interventional Cardiology Mark F. Conrad, MD Peter Fitzgerald, MD, PhD
West Virginia University School Vascular Surgery Interventional Cardiology
of Medicine Massachusetts General Hospital Stanford University Medical School
Charleston, West Virginia Boston, Massachusetts Stanford, California
Adam Beck, MD Michael Dake, MD Brian Fowler, BS, RVT
Vascular Surgery Interventional Radiology Vascular Ultrasound
UAB School of Medicine The University of Arizona Syntropic Core Lab
Birmingham, Alabama Tucson, Arizona Columbus, Ohio
James F. Benenati, MD Alun Davies, DM, DSc Rie Fukaya, MD
Interventional Radiology Vascular Surgery Vascular Medicine
Miami Cardiac & Vascular Institute Imperial College Stanford Health Care
Miami, Florida London, United Kingdom Stanford, California
Stephen Black, MD Koen R. Deloose, MD Lawrence A. Garcia, MD
Vascular Surgery Vascular Surgery Interventional Cardiology
St Thomas’ Hospital AZ Sint Blasius Steward St. Elizabeth’s Medical Center
London, England Dendermonde, Belgium Boston, Massachusetts
Marianne Brodmann, MD Brian DeRubertis, MD Mark J. Garcia, MD
Vascular Medicine Vascular Surgery Interventional Radiology
Medical University Graz UCLA-Ronald Reagan Medical Center EndoVascular Consultants
Graz, Austria Los Angeles, California Wilmington, Delaware
Kush R. Desai, MD Patrick Geraghty, MD
Interventional Radiology Vascular Surgery
Northwestern University Feinberg Washington University Medical School
School of Medicine St. Louis, Missouri
Chicago, Illinois
8 Please visit vivaphysicians.org for
updated program information.
Invited Faculty
Jay Giri, MD, MPH Barry T. Katzen, MD Marco Manzi, MD
Interventional Cardiology Interventional Radiology Interventional Radiology
Hospital of the University Miami Cardiac & Vascular Institute Foot & Ankle Clinic Policlinico
of Pennsylvania Miami, Florida Abano Terme
Philadelphia, Pennsylvania Abano Terme, Italy
Esther S.H. Kim, MD
Samuel Z. Goldhaber, MD Vascular Medicine James McKinsey, MD
Vascular Medicine Vanderbilt University Medical Center Vascular Surgery
Brigham and Women’s Hospital Nashville, Tennessee Mt. Sinai Ichan School of Medicine
Boston, Massachusetts New York, New York
Aaron Kithcart, MD, PhD
Bruce H. Gray, DO Vascular Medicine Manish Mehta, MD
Vascular Medicine Brigham and Women’s Hospital Vascular Surgery
Greenville Hospital System Boston, Massachusetts Vascular Health Partners, Community
Greenville, South Carolina Care Physicians
Paul B. Kreienberg, MD Glens Falls, New York
William Gray, MD Vascular Surgery
Interventional Cardiology Albany Medical College/Albany Medical Matthew Menard, MD
Lankenau Heart Institute Center Hospital Vascular Surgery
Wynnewood, Pennsylvania Albany, New York Brigham and Women’s Hospital
Boston, Massachusetts
Lanfroi Graziani, MD Steven Kum, MD
Interventional Cardiology Vascular Surgery Miguel Montero-Baker, MD
Istituto Clinico Città di Brescia Hospital Changi General Hospital Vascular Surgery
Brescia, Italy Singapore, Singapore Baylor College of Medicine
Houston, Texas
Stephan Haulon, MD Jeffrey Lawson, MD
Vascular Surgery Vascular Surgery Ali Moran, CNP
Hospital Marie Lannelongue Duke Health Vanderbilt University Medical Center
Le Plessis-Robinson, France Raleigh, North Carolina Nashville, Tennessee
Katherine Hays, DNP, ACNP-BC Arthur Lee, MD John Moriarty, MD
Vascular Medicine Interventional Cardiology Interventional Radiology
OhioHealth Heart and Vascular Institute The Cardiac & Vascular Institute UCLA
Columbus, Ohio Gainesville, Florida Los Angeles, California
Jeffrey Hull, MD Michael Lichtenberg, MD Erin Murphy, MD
Interventional Radiology Angiology Vascular Surgery
Richmond Vascular Center Karolinen-Hospital Hüsten Sanger Heart & Vascular Institute,
Richmond, Virginia Arnsberg, Germany Atrium Health
Concord, North Carolina
Cari Ice, RT Ian Loftus, MD
OhioHealth Vascular Surgery Jihad Mustapha, MD
Columbus, Ohio St George’s Vascular Institute Interventional Cardiology
London, United Kingdom Advanced Cardiac & Vascular
Osamu Iida, MD Amputation Prevention Center
Interventional Cardiology Charmaine Lok, MD Grand Rapids, Michigan
Kansai Rosai Hospital Nephrology
Amagasaki, Japan University Health Network Kari Nelson, MD
Ontario, Canada Interventional Radiology
Donald Jacobs, MD UCI School of Medicine
Vascular Surgery Joseph Lombardi, MD Orange, California
University of Colorado Anschutz Vascular Surgery
Medical Center Cooper University Health Care Janice Newsome, MD
Aurora, Colorado Camden, New Jersey Interventional Radiology
Emory University
Michael Jolly, MD Thomas Maldonado, MD Atlanta, Georgia
Interventional Cardiology Vascular Surgery
OhioHealth Riverside NYU Langone Health Gerard O’Sullivan, MD
Methodist Hospital New York, New York Interventional Radiology
Columbus, Ohio University College Hospital
Galway, Ireland
Schuyler Jones, MD
Interventional Cardiology
Duke University
Durham, North Carolina
9
Invited Faculty
Gustavo Oderich, MD Thom Rooke, MD Tiffany K. Street, RN
Vascular Surgery Vascular Medicine Vascular Surgery
Mayo Clinic Mayo Clinic Vanderbilt University Medical Center
Rochester, Minnesota Rochester, Minnesota Nashville, Tennessee
Christine Owen, MS, ACNP-BC, RNFA Eric Roselli, MD Edwin Takahashi, MD
Vascular Surgery Cardiothoracic Surgery Interventional Radiology
University of Maryland Community Cleveland Clinic Mayo Clinic
Medical Group Cleveland, Ohio Rochester, Minnesota
Glen Burnie, Maryland
Luis A. Sanchez, MD Giovanni Torsello, MD
Charles Keith Ozaki, MD Vascular Surgery Vascular Surgery
Vascular Surgery Barnes-Jewish Hospital Franziskus Hospital
Brigham and Women’s Hospital St. Louis, Missouri Münster, Germany
Boston, Massachusetts
Robert Schainfeld, DO Melissa A. Troyan, MSN, CNP
Jean Panneton, MD Vascular Medicine Interventional Cardiology
Vascular Surgery Massachusetts General Hospital OhioHealth Heart & Vascular
EVMS Division of Vascular Surgery Waltham, Massachusetts Columbus, Ohio
Norfolk, Virginia
Dierk Scheinert, MD Ramon Varcoe, MBBS, MS, PhD
Sahil A. Parikh, MD Angiology Vascular Surgery
Interventional Cardiology University Hospital Leipzig Prince of Wales Hospital
Columbia University Medical Center Leipzig, Germany Sydney, Australia
New York, New York
Darren Schneider, MD Suresh Vedantham, MD
Constantino Peña, MD Vascular Surgery Interventional Radiology
Interventional Radiology New York-Presbyterian, Weill Cornell Mallinckrodt Institute of Radiology
Miami Cardiac & Vascular Institute Medical Center St. Louis, Missouri
Miami, Florida New York, New York
Ido Weinberg, MD
Gregory Piazza, MD Eric Secemsky, MD Vascular Medicine
Vascular Medicine Interventional Cardiology Massachusetts General Hospital
Brigham and Women’s Hospital Beth Israel Deaconess Medical Center Boston, Massachusetts
Boston, Massachusetts Boston, Massachusetts
Christopher J. White, MD
Guy Pupp, DPM Surendra Shenoy, MD, PhD Interventional Cardiology
Podiatry Transplant Surgery Ochsner Medical Center
Providence Hospital Washington University School New Orleans, Louisiana
Southfield, Michigan of Medicine
St. Louis, Missouri Bret N. Wiechmann, MD
Dheeraj Rajan, MD Interventional Radiology
Interventional Radiology Mehdi Shishehbor, DO, PhD Vascular & Interventional Physicians
University Health Network Interventional Cardiology Gainesville, Florida
Toronto, Canada University Hospitals of Cleveland
Cleveland, Ohio Edward Woo, MD
Gaurav Rana, MD Vascular Surgery
Interventional Cardiology Mitchell Silver, DO MedStar Washington Hospital Center/
Hampden and Franklin County Interventional Cardiology Georgetown University Hospital
Cardiovascular Associates OhioHealth Riverside Washington, DC
Springfield, Massachusetts Methodist Hospital
Columbus, Ohio Hiroyoshi Yokoi, MD
Mahmood Razavi, MD Interventional Cardiology
Interventional Radiology Akhilesh Sista, MD Fukuoka Sanno Hospital
St Joseph Heart & Vascular Center Interventional Radiology Fukuoka, Japan
Orange, California New York University
New York, New York Thomas Zeller, MD, PhD
Angiology
Benjamin Starnes, MD Universitäts-Herzzentrum Freiburg
Vascular Surgery Bad Krozingen, Germany
University of Washington
Seattle, Washington
10 Please visit vivaphysicians.org for
updated program information.2019 Award Recipients
THE LIVE AWARD
Bruce H. Gray, DO, attended medical school at Ohio University’s Heritage College of Osteopathic
Medicine, followed by an internal medicine residency in Columbus, Ohio, and formal training in
vascular medicine, including peripheral intervention, at Cleveland Clinic. He is an early adopter of
new devices for carotid, AAA, PAD, and VTE treatment, and has participated in numerous clinical
trials involving all of these areas.
For the past 19 years, he has served as the Director of Endovascular Services at Prisma Health in
Greenville, South Carolina, and is a Professor of Surgery and Vascular Medicine at the University of
South Carolina School of Medicine, Greenville. He previously served on the board of the Society for Bruce H. Gray, DO
Vascular Medicine, and has also served as the Director of the American Board of Vascular Medicine
since its inception in 2003.
THE ATLAS AWARD
Christopher J. White, MD, graduated AOA from Case Western Reserve Medical School in Cleveland,
Ohio, in 1978, and completed his training in medicine and cardiology at Letterman Army Medical
Center (LAMC) in San Francisco (1978-1983). After completing his active duty military service in 1988,
he joined Ochsner Clinic in New Orleans, Louisiana, and in 1994, Dr. White moved to Glasgow, Scotland,
for HealthCare International (HCI). In 1997, he returned to Ochsner as Chairman of the Department
of Cardiology.
Dr. White is Past-President (2011-12) of SCAI and was Steering Committee Chairman (2006-2014) for
the NCDR’s carotid and peripheral revascularization database. Dr. White served as Editor-in-Chief of Christopher J. White, MD
Catheterization and Cardiovascular Interventions (2000-2010), is currently Associate Editor for JACC
Interventions, and has published over 300 peer-reviewed manuscripts in interventional cardiology
and vascular diseases. Dr. White is Professor and Chairman of the Department of Medicine for the
Ochsner Clinical School, and holds the positions of Medical Director for Value-Based Care and System
Chairman of Cardiovascular Diseases for the 14-hospital Ochsner Health System.
THE VASCULAR CAREER ADVANCEMENT (VCA) AWARD
Steven Kum, MD, received his medical degree from the National University of Singapore in 2000,
and subsequently embarked on his surgical training with the Royal College of Surgeons, obtaining his
Masters of Medicine and Fellowship in 2007.
Since 2015, Dr. Kum has been the director of vascular surgery at Changi General Hospital in Singapore,
and he was subsequently appointed as a visiting consultant in 2019. He maintains his practice at Mount
Elizabeth Novena Hospital in Singapore.
Dr. Kum is a clinical lecturer in both the Yong Loo Lin School of Medicine and Lee Kong Chian School of Steven Kum, MD
Medicine in Singapore, is a faculty member for General Surgical Residents for Singhealth, and is part of the
organizing committee of LINC and VERVE.
Parag J. Patel, MD, MS, is Associate Professor of Radiology and Surgery in the Division of Vascular &
Interventional Radiology at the Medical College of Wisconsin and Froedtert Memorial Lutheran Hospital
in Milwaukee, Wisconsin.
Dr. Patel graduated from medical school in 2002 and from his diagnostic radiology residency at Loyola
University Medical Center in 2007. He then completed his VIR Fellowship at Miami Cardiac & Vascular
Institute in Miami, Florida.
Dr. Patel joined the faculty at Medical College of Wisconsin (MCW) in 2008. He is the Program Director for Parag J. Patel, MD, MS
the VIR Fellowship and IR Residency training programs at MCW. He is currently on the Executive Council
for SIR and serves as the Graduate Medical Education Councilor.
For complete information about our 2019 award recipients, visit vivaphysicians.org/awards
11SCHEDULE AT-A-GLANCE
Morning Tracks
Morning Sessions
7:00AM - 8:00AM
SATURDAY
Exhibit Hours:
2:50PM - 3:20PM
SUNDAY The VEINS
Exhibit Hours:
7:15AM – 6:30PM
The VEINS Blue Sky Breakfast The VEINS
Satellite Session CLI Pre-Course
Aortic Pre-Course
MONDAY
Exhibit Hours: Nurses + Techs
7:15AM – 3:15PM
Fellows Session Global Theater
Satellite Session Nurses + Techs
TUESDAY
Exhibit Hours:
7:30AM – 5:15PM
Aortic Track Global Theater
CLI Track Strategies on the Frontline
WEDNESDAY Satellite Sessions The Roundtable
Exhibit Hours:
7:30AM – 5:15PM
Face-Off
Purple Theater
Hands-On Lab
Aortic Track Global Theater
THURSDAY CLI Track Strategies on the Frontline
Exhibit Hours:
7:30AM – 12:00PM The Roundtable
Purple Theater
12 Please visit vivaphysicians.org for
updated program information.Midday Afternoon Sessions Evening
The VEINS / Hands-On
The VEINS The VEINS Reception
Satellite Session
The VEINS
THE VEINS BLUE
CLI Pre-Course SKY BREAKFAST
Dialysis Pre-Course Join us on Monday
morning for a 1-hour
PharmacoRx Pre-Course
venous innovation summit.
Nurses + Techs: PharmacoRx This session will highlight
the latest treatment
Fellows Session Fellows Reception
Lunch & Exhibits/Satellite Sessions
technologies in venous
disease care.
Satellite Session
12:00PM – 1:15PM
Global Theater
Nurses + Techs: Global Theater
Strategies on the Frontline
The Roundtable
Face-Off
Purple Theater Satellite Sessions
Global Theater
Strategies on the Frontline VIVA RECEPTION
Join your colleagues at the
The Roundtable
VIVA Reception following
Face-Off the conclusion of all
sessions on Wednesday,
Purple Theater November 6. We will
Hands-On Lab VIVA Reception convene at Costa di Mare
to enjoy food, drinks, and
entertainment. Admission
Global Theater to the reception is
included in your course
Strategies on the Frontline registration. Guest tickets
may be purchased for an
The Roundtable
additional fee.
13MONDAY, NOVEMBER 4
Aortic Armageddon
7:45AM – 9:35AM EVAR
MONDAY
• Surveillance After EVAR: What Studies, How Often, and Pitfalls and Issues
• Large Neck EVAR: It’s Not OK
• Who Not to Treat With EVAR: Anatomic Issues and Physiologic Issues
• Angulated Neck Anatomy: Device Design Improvements and Adjuncts to Treat With Current
Devices
• Failed EVAR: When and How to Remove
• Common Iliac Aneurysm Branch Devices
• New Closure Options for Large Devices
• Mortality and Sac Exclusion Methods: Is There a Link?
• Endoleak: When to Treat Type II
• Transcaval Endoleak: How I Do It
• Aortoiliac Occlusive Disease and AAA: When and How to Use EVAR
• Migration and Outcome Definitions Need to be Updated to Assess New Indications and Designs
10:00AM – 11:00AM TEVAR
• TBAD—Defining High-Risk Criteria
• TBAD—When Design Features Matter: Lessons Learned and Outcomes of Devices
• Visceral Malperfusion Still There After TEVAR for TBAD—Now What?
• TEVAR for TAAA Device Outcomes, Improvements, and New Emerging Devices
• Spinal Drains With Thoracic Aortic Cases: When It Is Helpful and Complications of Use
• Traumatic Aortic Disruption: Defining When and How to Treat
• Carotid-subclavian Bypass or Transposition: When, How, and Outcomes
11:05AM – 12:00PM FEVAR TAAA
• Industry-Sponsored FEVAR Trials for TAAAs: Where We Stand Today
• CHIMPS (Chimneys, Periscopes, Snorkels): Outcomes and Perspective
• Gutter Endoleaks: Are They a Problem? What I Do and Don’t Do About Them
• Physician-Sponsored IDE: How I Got One, and Challenges in Start-up, Maintenance, and Funding
• Commercial FEVAR: Lessons Learned and Limitations
• Covered BE and SE Stents With F/BEVAR: Advantages and Disadvantages of Designs
14 Please visit vivaphysicians.org for
updated program information.Critical Limb Ischemia
7:45AM – 9:35AM DEFINING THE CLI EPIDEMIC
• Why Focus on CLI? How Relevant Is This to Your Practice Over the Next Decade?
• The Cost of CLI in the United States and the World
• Team Approach to CLI Care
MONDAY
• New Technologies for the Treatment of CLI
• Considerations for Developing an OBL-Based CLI Practice: Is This the Future?
• Digital Technology Platforms for the CLI Practice
• Controversy: Is There Value to Early Intervention in Preulcerative CLI Patients?
• Clinical and Angiographic Grading of CLI: Implications for Management
• Should We Image the CLI Patient or Go Directly to Angiography?
10:00AM – 12:00PM CLI BEST PRACTICES
• The Endovascular CLI Treatment Algorithm
• Is POBA the Gold Standard for Tibial Intervention? Data From RCTs and Contemporary
Observational Studies
• Key Problem: How to Perform Optimized Angioplasty—Vessel Sizing, Balloon Technique
• When and How to Use Atherectomy BTK
• When and How to Manage Dissections: Prolonged PTA, Tacks, and Stents
• The Approach to Multivessel Interventions
• Define the “No Option” Patient Population and Identify Potential Future Solutions
• Distal Bypass: What We Know and Will Learn From CRITISCH, BASIL-2, BEST-CLI, and Other Trials
and Registries
• Controversy: How and When to Perform Distal Bypass vs Endovascular Therapy
• Case Presentation
1:15PM – 2:45PM ADVANCED CLI
• Key Problem: Understanding Tibial and Pedal Anatomy and Variants
• How Important Is the Pedal Loop and Should It Always Be Revascularized?
• Plantar-Pedal Loop Techniques
• Very Distal Angioplasty—Arcuate, Metatarsal, and Digital Artery Interventions
• Controversy: How Relevant Are the Concepts of Angiosomes, Angiographosomes, and Targeted
Tibial Revascularization?
• The Toe After the Flow: Can Ischemic Wound Care Be Standardized?
• Identifying and Caring for Combined Arterial and Venous Leg Ulcers
• Keynote: What Have We Learned About Treating CLI Over the Past 5 Years? In 5 Years, What Will
Be State-of-the-Art?
3:05PM – 4:05PM CLI CHALLENGES
• Key Problem: What Are the Most Important Endpoints in CLI Patients?
• Approaches for Restenotic and Repeatedly Stenotic (or Occluded) Lesions
• Controversy: How to Assess Intraprocedural Perfusion, and Does It Matter?
• What to Do for Acute Procedural Thrombosis and Embolization
• Guidelines and Beyond—Pharmacotherapy Following Basic and Difficult Interventions
• Case Presentation
4:10PM – 5:10PM CLI: CASES, CASES, CASES!
• My Most Challenging Calcified Tibial Case
• Complex Pedal Loop Reconstruction
• Deep Venous Arterialization—A New Option for the “No Option” Patient
15Dialysis
1:15PM – 2:45PM UPDATE ON DIALYSIS TREATMENTS
• Kidney Disease Outcomes Quality Initiative (KDOQI) Update
• Kidney Failure Risk Equation (KFRE)—When It Works, When It Doesn’t
• Tunneled Catheters: Is There Really Any Difference?
MONDAY
• When Is Urgent Peritoneal Dialysis (PD) Indicated?
• Dialysis Steal: Diagnosis and Treatment
• Current Practice: Stent Grafts in Dialysis Access
• When to Declot, and When Not To
• Percutaneous Declot: Getting Out of Trouble
3:05PM – 5:00PM NEW TECHNOLOGIES AND TRIALS IN DIALYSIS
• Alternative Surgical Access
• Where Does Percutaneous Arteriovenous Fistula (AVF) Fit?
• WavelinQ Technique and Results
• Ellipsys Technique and Results
• Current Practice: DCBs in Dialysis Access
• Vonapanitase Update
• Where Is HUMANITY Today?
• Sirolimus AVF Trial
• Stenosis Prevention—The Future
PharmacoRx
1:15PM – 2:45PM PAD
• What Is the Right Postendovascular Medical Regimen?
• What Is the Right Postsurgical Bypass Medical Regimen?
• Patient With PAD and an ACS 1 Year Ago Is on DAPT—What’s the Right Antithrombotic Therapy
Now?
• What Is the Right Postendovascular Medical Regimen in the Anticoagulated Patient?
• What Is the LDL Goal in a Patient With PAD +/- Intervention?
• Which Diabetic Therapies Should I Know and Prescribe for My PAD Patients?
• How Can I Incorporate Smoking Cessation Into My Practice?
• What Drugs Are Harmful in PAD?
• What Is the Role of Cilostazol in Stent Patency?
3:05PM – 5:00PM AAA/CAROTID/VTE
• What Is the Right Medical Therapy for AAA Patients?
• What Antithrombotic Therapy Should Be Used in Asymptomatic Carotid Artery Stenosis?
• What Is the Right Antiplatelet Therapy for Carotid Artery Disease After Intervention?
• Does the Presence of Carotid Stenosis Mandate the Same Medical Therapy As PAD?
• What Medical Therapy Should Be Applied After Small Stroke or TIA?
• How Do I Decide the Dose of Infused Lytics in Catheter-Directed PE Thrombolysis?
• When Is Endovascular Thrombectomy Superior to CDT?
• Are There Meaningful Differences Between DOAC, and Why for DVT?
• For My DVT Patients With Cancer, Are We Still Stuck in the LMWH Era?
• Which Patients Don’t Benefit From Extended Duration Low-Dose DOAC Therapy to Prevent VTE
Recurrence?
• Management of Anticoagulation Bridging Around an Invasive Procedure
16 Please visit vivaphysicians.org for
updated program information.GLOBAL TUESDAY, NOVEMBER 5
THEATER
8:05AM – 9:05AM MOST CONTROVERSIAL CLINICAL CHALLENGES OF 2019
• What Are the Major Demographic Trends in Vascular Disease From Head to Toe, and How Will They
TUESDAY
Affect My Future Practice?
• Shifting Worldwide Regulatory Priorities: How Will Changes in 510k and CE Mark Process Affect
Device Availability for Patients?
• Will DCB and DES Have a Future in Lower Extremity Revascularization? Update Since the Vascular
Leaders Forum
• Endovascular Is the Best Treatment for Rupture AAA—Right?
• We Know Percutaneous Pulmonary Embolectomy Saves Lives, but When Will It Gain Traction in
the Community?
9:05AM – 9:10AM LIVE AWARD
A Leader In EndoVascular Education Award—The LIVE Award recognizes those
vascular specialists who have dedicated their professional careers to educating
students, postgraduate trainees, and peers in all aspects of vascular medicine and
intervention.
VIVA is proud to honor the 2019 recipient, Bruce H. Gray, DO.
9:10AM – 9:15AM ATLAS AWARD PRESENTATION
A Teacher, Leader, And Scholar Award—The ATLAS Award celebrates the career
and impact of physicians who have distinguished themselves as scholars and
leaders in their respective vascular fields. They have committed their careers
to advancing the care of patients with vascular disorders, and they have taught
countless numbers of physicians techniques to expand care across the United
States and around the world.
VIVA is proud to honor the 2019 recipient, Christopher J. White, MD.
9:15AM – 10:15AM LATE-BREAKING CLINICAL TRIALS
10:45AM – 12:00PM LIVE CASE DEMONSTRATIONS
Heart Hospital Baylor Plano
Live Case Site Operator: Tony Das, MD
Dallas, Texas
1:15PM – 2:15PM LATE-BREAKING CLINICAL TRIALS
17GLOBAL
THEATER
TUESDAY
2:15PM – 2:55PM KEYNOTE: THE FUTURE OF MEDICINE
Innovations in Vascular Care: New Tools, Ideas, and What’s on the Horizon
Peter Fitzgerald, MD, PhD
Future of Medical Education: How Do We Prepare the Next Generation?
Michael Dake, MD
WHY AN OFFICE-BASED LAB (OBL)
2:55PM – 3:30PM SHOULD BE PART OF YOUR PRACTICE
• How OBLs Make Care Better and Safer
• Quality Behind the Scenes: How to Avoid Disaster
• Where Is This Leading? Envision the Future of Office-Based Procedures
4:00PM – 5:15PM LIVE CASE DEMONSTRATIONS
Heart Hospital Baylor Plano
Live Case Site Operator: Tony Das, MD
Dallas, Texas
18 Please visit vivaphysicians.org for
updated program information.THE
The ROUNDTABLE
Roundtable
2:15PM – 2:50PM DIALYSIS: HOW TO MAINTAIN THE BUZZ
ROUNDTABLE
THE First”—Who Is Not a Candidate and Who Is? Have We Gone Too Far and Will Percutaneous
• “Fistula
TUESDAY
Fistula Placement Change That?
• Percutaneous Fistula Creation: Patient Selection and Technique
• Surgical Options for Fistula and Graft Placement: Preferred Approaches and Innovative Options
• Salvage of Dialysis Graft or Fistula: What Tools Do You Need?
2:55PM – 3:30PM ACUTE AND CHRONIC DVT
• Impact of New Devices and Strategies on How We Perform Percutaneous Venous Thrombectomy
• Managing the Late-Presenting DVT: How Does It Affect Patient Selection and Technique?
• My Tips and Pearls for Iliac Vein Stenting
INTEGRATING DUPLEX ULTRASOUND INTO YOUR
4:00PM – 5:15PM PRACTICE AND OPTIMIZING ITS USE
• Noninvasive Imaging in CLI: Value and Limitation
• Pitfalls in Carotid Duplex Imaging
• Ultrasound Access in Venous Interventions
• Duplex in Diagnosis of Access Site Complications
• 3D and X-Plane Imaging in Vascular Clinical Practice
• Hemodialysis Access Maturation and Ultrasound Surveillance
• Surveillance of Aortic Stent Grafts: Can Duplex Replace or Supplant Axial Imaging?
• Duplex Diagnosis of Iliac Vein Obstruction and for Surveillance
• Duplex in Ovarian Vein Reflux
VIVA
Strategies on
the Frontline
2:15PM – 2:50PM AORTIC EMERGENCIES
2:55PM – 3:30PM ACUTE LIMB ISCHEMIA
ALTERNATIVE LOWER EXTREMITY ACCESS TO COMPLETE
4:00PM – 4:45PM A DIFFICULT CASE: PEDAL, TIBIAL, POPLITEAL, SFA
PURPLE THEATER
DISRUPTIVE TECHNOLOGY FOR ENDOVASCULAR
4:00PM - 5:00PM THERAPY: PART 1
19WEDNESDAY, NOVEMBER 06
Aortic Track
WEDNESDAY
7:05AM – 7:55AM AORTIC DISSECTION
• Type A Aortic Dissection in the Ascending Aorta: Endo Rx
• Pros and Cons of Frozen Elephant Trunk for Acute Type A Aortic Dissection—Will It Be Safer?
• Treatment of False Lumen—Continued Perfusion Behind My Device
• Can We Prevent Stent Graft-Induced Retrograde TAAD? Understanding Aortic Morphology, Stent
Graft Design, and Avoiding Pitfalls
• Distal Aortic Dilatation After TEVAR for TBAD: When, Why Does It Happen, and What’s the Best
Solution?
• Treatment of Abdominal Aortic, Visceral, and Iliac Re-Entry Sites: When and How
CLI Track
7:05AM – 7:55AM DEEP VENOUS ARTERIALIZATION: A DEEP ANALYSIS
• Deep Venous Arterialization (DVA)—Pathophysiology and Rationale
• DVA Tools, Techniques, and Procedural Evolution
• Patient Selection and Postprocedural Clinical Management
• Clinical Trials Pathway and Results
• Surgical Venous Arterialization and Comparison to Percutaneous DVA
GLOBAL
THEATER
8:00AM – 8:05AM REVIEW OF TUESDAY’S LIVE CASES
8:05AM – 8:15AM VCA AWARD
VIVA and LINC have collaborated to develop the Vascular
Career Advancement Award to recognize young physicians
who have shown outstanding leadership in the vascular
field. Recipients are selected for their dedication to a
philosophy of multidisciplinary vascular care and improving
the care and outcomes of patients with vascular disease.
VIVA is proud to honor the 2019 recipients, Steven Kum, MD; Steven Kum, MD Parag J. Patel, MD, MS
and Parag J. Patel, MD, MS.
20 Please visit vivaphysicians.org for
updated program information.8:15AM – 9:15AM LINC AT VIVA—LIMB SALVAGE PEARLS
• Will Drug Delivery Play a Role in Improving BTK Patency, and If So, When?
• Severe Venous and Arterial Disease Aren’t So Different: Unmet Needs and Challenges
• Strategies for Optimizing Acute Results of BTK Intervention: Balloon Sizing, Best Minimal Lumen
Diameter, Managing Dissections, and More
WEDNESDAY
• Trial Endpoints That Make Sense: Patency, Wound Healing, Target Lesion Revascularization,
Amputation-Free Survival—Which One Is Best?
• Significant Recent and Ongoing Trials That Are Shaping Practice
• Acute Procedural Endpoints: How Many Tibials and Which to Revascularize? How to Know When
You’re Done
9:15AM – 10:15AM LATE-BREAKING CLINICAL TRIALS
10:45AM – 12:00PM LIVE CASE DEMONSTRATIONS
University Hospital Leipzig
Live Case Site Operator: Andrej Schmidt, MD
Leipzig, Germany
1:15PM – 2:15PM LATE-BREAKING CLINICAL TRIALS
2:15PM – 3:30PM LIVE CASE DEMONSTRATIONS
Auckland Hospital
Live Case Site Operator: Andrew Holden, MBChB
Auckland, New Zealand
IS THIS THE END OF DRUG-ELUTING DEVICES
4:00PM – 5:00PM OR THE BEGINNING?
THE ROUNDTABLE
ADVANCED CAROTID TECHNIQUES:
8:15AM – 9:15AM HOW TO MAKE IT SAFER
•
THE ROUNDTABLE
Use of Mesh Covered Stents for Carotid Bifurcation Stenosis: Device Selection and Technique
• TCAR: How I Do It
• Carotid Protection and Management During Arch Reconstruction and Structural Heart Procedures
• Stroke Intervention: Clot Retrieval in the Setting of a Critical/Symptomatic Carotid Stenosis
• Management of Early and Late Carotid Stent Occlusion
10:35AM – 11:10AM BTK ATHERECTOMY AND PLAQUE MODIFICATION
• What Is the Embolization Risk of Atherectomy Below the Knee?
• BTK Plaque Morphology: What Can We Learn and How Does It Drive Treatment Choice?
• Data Review for BTK Atherectomy
• Comparison of Directional, Rotational, and Orbital Atherectomy Below the Knee—When to Use
Which Approach
21PROTECTING OUR PATIENTS AND OURSELVES FROM
11:25AM – 12:00PM RADIATION: SIMPLE THINGS WE NEED TO DO
WEDNESDAY
• Cancer Risk Is on Every Interventionist’s Mind: How Concerned Should We Be?
• Basic Stepwise Maneuvers to Protect Yourself
• Innovations and Technologies on the Horizon That Will Reduce Radiation Risk
2:15PM – 3:30PM LINC AT VIVA—CLI INTERVENTIONS: LATEST ADVANCES
• Multilevel Disease: When to Stage It, When to Fix Everything, and to Know When You’ve Done
Enough for Success
• Retrograde Access in Revascularization for CLI: When and How to Do It
• What Role Does DCB Play in CLI Patients?
• Options for Reconstruction in the CLI Patient With TASC D+++ Femoropopliteal Disease
• Tack-Optimized Angioplasty in the Tibial Arteries: Technique and Results
• Identifying No-Option Patients and When to Consider Deep Venous Arterialization: Technique and
Results
4:00PM – 5:15PM VASCULAR LAB
• IAC Standardization for Carotid Duplex Criteria: Rationale and Update
• Subtle to Important Findings in Subclavian/Vertebral Duplex: Implications
• Noninvasive Surveillance of Aortoiliac Interventions—Is Duplex Sufficient?
• Point-of-Care Ultrasound in Vascular Practice—How Can It Help?
• Complex Mesenteric Duplex
• What I Think About USPTF Recommendations Regarding Screening ABIs
• Management of Groin Complications in the Vascular Lab
• How to Assess Carotid Artery Vulnerable Plaque
• Emerging Perfusion Testing for CLI Assessment
VIVA
Strategies on
the Frontline
EMBOLIZATION TECHNIQUES:
8:15AM – 9:15AM COILS, OCCLUDERS, AND GLUES
10:45AM – 11:20AM TREATMENT OF PERSISTENT TYPE II ENDOLEAKS
11:25AM – 12:00PM CONGENITAL AVMS AND TRAUMATIC AVFS
INNOMINATE, SUBCLAVIAN, AND VERTEBRAL ARTERY
2:15PM – 2:50PM LESIONS: SAFELY MANAGING THE CHALLENGES
2:55PM – 3:30PM CAROTID CASES: CEA VS TF—CAS VS TCAR
4:00PM – 4:45PM COMPLEX AORTOILIAC INTERVENTIONS
22 Please visit vivaphysicians.org for
updated program information.PURPLE THEATER
WEDNESDAY
DISRUPTIVE TECHNOLOGY FOR ENDOVASCULAR
8:15AM - 9:15AM THERAPY: PART 2
10:45AM - 12:00PM GOVERNMENT REGULATORY SESSION
Case Complications
PRACTICE MANAGEMENT AND THE BUSINESS OF
2:15PM - 2:50PM VASCULAR PRACTICE
• Coding and Billing Correctly to Optimize Success
• Independent Practice vs Hospital Employment
• How to Expand Your Practice: New Procedures and Programs to Include
• Biggest Challenges in Practice Management Today and How to Deal With Them
2:55PM - 3:30PM BELOW-THE-ANKLE INTERVENTION
• Technique for BTA Angioplasty: Wires, Catheters, Balloons, and Tips for Success
• Approaches to the Pedal Arch and Pedal Loop Reconstruction
• Retrograde Access via Metatarsal Arteries—Really??
• Indication and Technique for Endovascular Deep Venous Arterialization
Deep Dive
TECHNICAL TIPS: PERCUTANEOUS THROMBECTOMY IN
4:00PM - 4:45PM THE ARTERIAL OR VENOUS SYSTEMS
• Getting the Most From Aspiration Techniques
• Making Pharmacomechanical Thrombectomy Work: Comparison of Devices
• Cardiogenic Peripheral Emboli: What Algorithm?
• Large Volume Venous Thrombus: How to Manage IVC and Iliofemoral
23THURSDAY, NOVEMBER 7
Aortic Track
7:05AM – 7:55AM THORACOABDOMINAL AORTA
THURSDAY
• Planning F/BEVAR—How I Do It in 2D, and Will It Evolve to 3D?
• Advances in Image Guidance for Managing Complex Aortic Morphology
• Complex TAAs: The Best Evidence for Using Fenestrated and Branched Stents Grafts Over Parallel
Stent Grafts
• Complex TAAs: The Best Evidence for Using Parallel Stent Grafts Over Fenestrated and Branched
Stent Grafts
• Complex TAAs: Operator Experience Matters the Most; Fenestrated, Branched, and Off-the-Shelf
Parallel Stent Grafts Are Comparable
• Type I and Gutter Endoleaks—When to Intervene and How
CLI Track
7:05AM – 7:55AM EMERGING AND DISRUPTIVE TECHNOLOGIES
• Tibial Scaffolds
• Emerging Drug Delivery Platforms
• Dissection Repair
• Calcium Tools: Lithoplasty, Eximo, Serration, Scoring
• Stem Cell and Cytokine Therapies
GLOBAL
THEATER
8:00AM – 8:05AM REVIEW OF WEDNESDAY’S LIVE CASES
8:05AM – 9:10AM LIVE CASE DEMONSTRATIONS
North Central Heart
Live Case Site Operator: J. Michael Bacharach, MD
Sioux Falls, South Dakota
9:10AM – 10:10AM PULMONARY EMBOLISM
• Are We Making Progress in PE Management? What Is the Latest Clinical Data?
• The Role of the PERT Program in Attacking the PE Problem
• Management of Massive PE—Extreme Measures for the Most Compromised Patients
• Submassive PE: When to Intervene and When to Treat Medically
• New Tools and Devices for PE Management—What’s New and What’s Next
• The Future of PE Management: A Look 5 Years Down the Road
10:35AM – 11:00AM FACE-OFF WINNERS CIRCLE
24 Please visit vivaphysicians.org for
updated program information.11:00AM – 12:00PM LIVE CASE DEMONSTRATIONS
Stanford University Medical Center
Live Case Site Operator: Jason T. Lee, MD
Stanford, California
THURSDAY
1:15PM – 2:45PM FEMORAL POPLITEAL
• Vessel Preparation: Now Recognized for Its Value in Making All Femoral Popliteal Treatments
More Efficacious
• DCB vs DES Paradigms: Which Patients for Which Treatment?
• What’s Next After Paclitaxel?
• Scaffolds: What Are the Choices?
• Atherectomy: Options, Patient Selection, Latest Technique
• Periprocedural Management for Best Results: Medical Regimen, Surveillance, and When to
Re-intervene
• Current Algorithm for Femoral Popliteal Occlusive Disease Management
MY WORST NIGHTMARE: CASES THAT PUSH THE BEST
2:45PM – 3:30PM OF THE BEST
3:30PM – 3:35PM CLOSING REMARKS
25THE ROUNDTABLE
ATHERECTOMY MINICOURSE: WHERE DOES IT FIT IN
THURSDAY
8:05AM
•
ROUNDTABLE
THE– 9:05AM YOUR PRACTICE?
Overview of Atherectomy Devices: What Is Each Device Best at Doing?
• Orbital Atherectomy: Tips, Pearls, and Cases
• Directional Atherectomy: Patient Selection and Technique
• Rotational Atherectomy Devices: When to Choose and How to Use
• Managing and Avoiding Complications of Atherectomy, and When and How to Use Distal
Protection
9:10AM – 10:10AM ENDOLEAK MANAGEMENT AFTER EVAR AND TEVAR
• Surveillance Protocol After EVAR and TEVAR: How Often and What Modality?
• EVAR and TEVAR: How Best to Identify and Treat Type I Endoleaks During the Index Procedure and
When They Are Discovered Later
• Algorithm for Managing Persistent Type II Endoleaks After EVAR: When and How to Intervene
• Endoleak Due to Graft Failure, Type IIIa and IIIb: How to Identify and Manage, and What Are the
Common Denominators of Failure?
• New Ideas and Technologies That May Help Solve the Endoleak Problem
• When You Have Tried Everything Else: Open Procedures for Endoleak Management, Endograft
Salvage, and When to Remove
10:35AM – 11:10AM OFFICE-BASED LABS
• How Best to Triage the Right Patients to the Optimal Care Setting
• Results Assessment and Quality Improvement in the Office-Based Setting
• What Can We Learn From Multidisciplinary Interactions and Teamwork in an Office-Based Lab?
• Management of Emergencies in the Office-Based Setting: How Should You Prepare? What’s the
Management Plan?
11:15AM – 12:00PM CALCIFICATION: THE LAST FRONTIER
• Basics of Calcification: How Did It Get There and What Are the Different Morphologies?
• Calcium Scoring Systems: Which One Should We Use and What Is on the Horizon?
• Technical Tips for Crossing Calcified Lesions
• Does Calcium Prevent Drug Uptake?
• Scoring, Serration, Lithoplasty, Atherectomy: Which One to Use in the Calcified Lesion
1:15PM – 2:10PM BELOW-THE-KNEE DRUG DELIVERY
• The Value Proposition for Drug Delivery in CLI Patients Is Different Than in Claudicators
• When to Use DCB and When to Use DES for Short (VIVA
Strategies on
THURSDAY
the Frontline
COMMON FEMORAL ARTERY CASES: ENDARTERECTOMY
8:05AM – 9:05AM OR ENDOVASCULAR APPROACH
9:10AM – 10:10AM MANAGING IATROGENIC VASCULAR TRAUMA: BAILOUTS
10:35AM – 11:10AM MY MOST CHALLENGING DIALYSIS CASE OF THE YEAR
HOW I DO IT: LONG SEGMENT AND HYBRID FEM-POP
11:15AM – 12:00PM PROCEDURES
DIFFICULT VENA CAVA FILTERS AND DEEP VEIN
1:15PM – 2:10PM RECONSTRUCTION
2:15PM – 3:15PM CHALLENGING BTK CASES
PURPLE THEATER
Deep Dive
ACCESS CLOSURE: CHOOSING THE RIGHT CLOSURE
8:05AM – 9:05AM DEVICE, AVOIDING AND MANAGING COMPLICATIONS
9:10AM – 10:10AM THE ART OF CROSSING THE CHALLENGING CTO
10:35AM – 11:10AM ALTERNATIVE ACCESS
Case Complications
IATROGENIC VASCULAR COMPLICATIONS: DIAGNOSIS
11:15AM – 12:00PM AND MANAGEMENT
27You can also read
